Urgent.News

What's breaking now, across thousands of outlets.

Tech

Strong chip exports expected to spill over into private consumption from next year: BOK report

Korea's semiconductor export boom, driven by global demand for artificial intelligence (AI) infrastructure, is expected to give private consumption a more meaningful boost starting next year, a central bank report showed Thursday. "Recently, the Korean economy has seen a significant acceleration in growth, driven by the strong semiconductor market, but the pace of growth in private consumption…

Strong chip exports expected to spill over into private consumption from next year: BOK report

Korea's semiconductor export boom, fueled by global demand for artificial intelligence infrastructure, is set to significantly bolster private consumption starting next year, according to a central bank report released Thursday. While the Korean economy has experienced a notable acceleration in growth due to the robust semiconductor market, the pace of growth in private consumption has remained relatively sluggish.

The Bank of Korea (BOK) reported that Asia's fourth-largest economy expanded by 3.8% in the first half of the year compared to the same period last year, with private consumption growing by 2.6% over the same timeframe. This economic growth was primarily propelled by strong exports, led by the surge in semiconductor shipments. In September alone, exports increased by 83.5% year-on-year, reaching a record $120.9 billion, while semiconductor exports skyrocketed by 263% to an unprecedented $60.3 billion.

The BOK's report suggests that private consumption has been on a steady recovery since hitting a low in the first quarter of 2025. The extent to which the recovery remains strong and sustainable will hinge on the widespread distribution of the benefits generated by the economic expansion.

Written by urgent.news from The Korea Times's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.

This story

This is one outlet's version. Read the fullest account.

Read the original at koreatimes.co.kr →

More in Tech

Celltrion Secures Global Rights to Kaigene’s KG013, Expanding Autoimmune Drug Pipeline

Celltrion is strengthening its next-generation drug development portfolio by securing global rights to KG013, an investigational antibody therapy for autoimmune diseases developed by U.S.-based…

  • Celltrion secures global rights to KG013 antibody therapy for $580.5 million.
  • KG013 targets APRIL protein to treat IgAN and potentially other immune conditions.
  • Partnership expands Celltrion's autoimmune drug pipeline with two additional Kaigene therapies.

More from Thursday 22 October →